Potassium Chloride Tablet, Extended Release
Product Images NDC 68382-740

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 68382-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kcl Tab 10meq (083947ee Abb8 4e07 B3a9 A8ad10c23acf 01)

Potassium Chloride Extended-release Tablets, USP 10 mEq K, 750 mg strength, oral extended-release tablets in a 100-tablet package by Zydus Pharmaceuticals USA Inc. The label states the dosage form and strength, includes a tablet image, barcode, and manufacturer details from Cadila Healthcare Ltd., India.*

FDA Label Image

Kcl 20meq (083947ee Abb8 4e07 B3a9 A8ad10c23acf 02)

Potassium Chloride Extended-release Tablets, USP 20 mEq oral extended-release tablets shown with active ingredient strength prominently displayed. The label indicates a package containing 100 tablets for prescription use only, labeled by Zydus Pharmaceuticals USA Inc. The label also includes storage instructions and manufacturer information from Cadila Healthcare Ltd., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.